Literature DB >> 15659753

Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin.

L Lopalco1, C Barassi1, C Paolucci1, D Breda1, D Brunelli1, M Nguyen2, J Nouhin2, T T Luong3, L X Truong3, M Clerici4, G Calori1, A Lazzarin1, G Pancino5, S E Burastero1.   

Abstract

Unconventional immune responses have been demonstrated in individuals who, despite repeated exposure to human immunodeficiency virus (HIV) infection, remain seronegative. As environmental exposure to pathogens and genetic background may modulate immune responses differentially, one Italian and two Asian populations of HIV-1-exposed seronegative individuals were studied. In serum samples from each group, IgG to CCR5, IgG to CD4 and IgA to gp41 were measured, which were previously described as markers of unconventional immunity in HIV-exposed seronegative Caucasians. Given the importance of conformational epitopes in virus-cell interactions, IgG to CD4-gp120 complex was also measured. It was found that markers of HIV exposure were present in all populations studied. HIV-specific humoral responses (IgA to gp41 and IgG to CD4-gp120 complex) were extremely significant predictors of HIV exposure (P<0.0001 in both cases), whereas the predictive values of anti-cell antibodies (anti-CCR5 and anti-CD4) varied between populations. Evidence is provided for the correlation of these differences with route of exposure to HIV and level of natural antibodies to cross-reactive microbial antigens. In conclusion, exposed seronegative individuals of ethnically different origins display similar signs of HIV-dependent unconventional immunity. A specific relevance must be attributed to different innate and acquired factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659753     DOI: 10.1099/vir.0.80585-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

Review 1.  Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.

Authors:  Barton F Haynes; David C Montefiori
Journal:  Expert Rev Vaccines       Date:  2006-06       Impact factor: 5.217

2.  Infection of macrophages and dendritic cells with primary R5-tropic human immunodeficiency virus type 1 inhibited by natural polyreactive anti-CCR5 antibodies purified from cervicovaginal secretions.

Authors:  Jobin Eslahpazir; Mohammad-Ali Jenabian; Hicham Bouhlal; Hakim Hocini; Cédric Carbonneil; Gérard Grésenguet; François-Xavier Mbopi Kéou; Jérôme LeGoff; Héla Saïdi; Mary Requena; Nadine Nasreddine; Jean de Dieu Longo; Srinivas V Kaveri; Laurent Bélec
Journal:  Clin Vaccine Immunol       Date:  2008-03-19

Review 3.  Mucosal correlates of protection in HIV-1-exposed sero-negative persons.

Authors:  Ruizhong Shen; Phillip D Smith
Journal:  Am J Reprod Immunol       Date:  2014-01-16       Impact factor: 3.886

Review 4.  Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS.

Authors:  Marcus Kaul; Stuart A Lipton
Journal:  J Neuroimmune Pharmacol       Date:  2006-06       Impact factor: 4.147

5.  Two amino acid substitutions within the first external loop of CCR5 induce human immunodeficiency virus-blocking antibodies in mice and chickens.

Authors:  Claudia Pastori; Alberto Clivio; Lorenzo Diomede; Roberto Consonni; Giacomo M S De Mori; Renato Longhi; Giorgio Colombo; Lucia Lopalco
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

6.  Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed against a gp120-induced epitope of CD4.

Authors:  Samuele E Burastero; Barbara Frigerio; Lucia Lopalco; Francesca Sironi; Daniela Breda; Renato Longhi; Gabriella Scarlatti; Silvana Canevari; Mariangela Figini; Paolo Lusso
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

Review 7.  Natural anti-CCR5 antibodies in HIV-infection and -exposure.

Authors:  Lucia Lopalco
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

8.  Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans.

Authors:  Evélyne Bégaud; Loïc Chartier; Valéry Marechal; Julienne Ipero; Josianne Léal; Pierre Versmisse; Guillaume Breton; Arnaud Fontanet; Corinne Capoulade-Metay; Hervé Fleury; Françoise Barré-Sinoussi; Daniel Scott-Algara; Gianfranco Pancino
Journal:  Retrovirology       Date:  2006-06-22       Impact factor: 4.602

Review 9.  Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection.

Authors:  Samuele E Burastero; Mariangela Figini; Barbara Frigerio; Paolo Lusso; Luca Mollica; Lucia Lopalco
Journal:  J Transl Med       Date:  2009-11-28       Impact factor: 5.531

10.  IgM Repertoire Biodiversity is Reduced in HIV-1 Infection and Systemic Lupus Erythematosus.

Authors:  Li Yin; Wei Hou; Li Liu; Yunpeng Cai; Mark Andrew Wallet; Brent Paul Gardner; Kaifen Chang; Amanda Catherine Lowe; Carina Adriana Rodriguez; Panida Sriaroon; William George Farmerie; John William Sleasman; Maureen Michels Goodenow
Journal:  Front Immunol       Date:  2013-11-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.